Mingsong Wang

1.2k total citations
33 papers, 761 citations indexed

About

Mingsong Wang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mingsong Wang has authored 33 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 11 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mingsong Wang's work include RNA modifications and cancer (9 papers), Ubiquitin and proteasome pathways (6 papers) and Cancer-related molecular mechanisms research (5 papers). Mingsong Wang is often cited by papers focused on RNA modifications and cancer (9 papers), Ubiquitin and proteasome pathways (6 papers) and Cancer-related molecular mechanisms research (5 papers). Mingsong Wang collaborates with scholars based in China, United States and South Korea. Mingsong Wang's co-authors include Fengqing Hu, Haibo Xiao, Xiao Xie, Ju Mei, Fangbao Ding, Liang-jian Zou, Shengdong Huang, Zhiyun Xu, Xilong Lang and Guoqing Li and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Mingsong Wang

33 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingsong Wang China 17 549 284 106 78 67 33 761
Lixiang Wang China 17 685 1.2× 318 1.1× 102 1.0× 22 0.3× 38 0.6× 21 867
Aristeidis E. Boukouris Canada 8 331 0.6× 129 0.5× 99 0.9× 23 0.3× 46 0.7× 13 493
Declan J. McKenna United Kingdom 15 404 0.7× 327 1.2× 119 1.1× 12 0.2× 44 0.7× 37 696
Yu Qi China 19 599 1.1× 305 1.1× 234 2.2× 30 0.4× 49 0.7× 55 951
Walid Mahfouf France 14 452 0.8× 137 0.5× 86 0.8× 22 0.3× 178 2.7× 20 675
Chuanchun Han China 21 1.0k 1.9× 481 1.7× 149 1.4× 10 0.1× 131 2.0× 38 1.2k
Justine Bellier Belgium 11 270 0.5× 159 0.6× 211 2.0× 140 1.8× 38 0.6× 11 632
Romain Riscal United States 9 492 0.9× 356 1.3× 192 1.8× 12 0.2× 95 1.4× 12 822
Mohan R. Kaadige United States 12 548 1.0× 220 0.8× 100 0.9× 8 0.1× 39 0.6× 27 717

Countries citing papers authored by Mingsong Wang

Since Specialization
Citations

This map shows the geographic impact of Mingsong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingsong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingsong Wang more than expected).

Fields of papers citing papers by Mingsong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingsong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingsong Wang. The network helps show where Mingsong Wang may publish in the future.

Co-authorship network of co-authors of Mingsong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Mingsong Wang. A scholar is included among the top collaborators of Mingsong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingsong Wang. Mingsong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Xing, Lei Liu, Dan Liu, et al.. (2024). Unveiling the methionine cycle: a key metabolic signature and NR4A2 as a methionine-responsive oncogene in esophageal squamous cell carcinoma. Cell Death and Differentiation. 31(5). 558–573. 11 indexed citations
2.
Liu, Dan, Xing Jin, Guanzhen Yu, et al.. (2021). Oleanolic acid blocks the purine salvage pathway for cancer therapy by inactivating SOD1 and stimulating lysosomal proteolysis. Molecular Therapy — Oncolytics. 23. 107–123. 9 indexed citations
3.
Jiang, Yanyu, Wei Cheng, Lihui Li, et al.. (2020). Effective targeting of the ubiquitin-like modifier NEDD8 for lung adenocarcinoma treatment. Cell Biology and Toxicology. 36(4). 349–364. 12 indexed citations
4.
Liang, Zhigang, et al.. (2020). HAX1 enhances the survival and metastasis of non‐small cell lung cancer through the AKT/mTOR and MDM2/p53 signaling pathway. Thoracic Cancer. 11(11). 3155–3167. 15 indexed citations
5.
Li, Lihui, Wenjuan Zhang, Xiaojun Liu, et al.. (2020). The CRL3BTBD9 E3 ubiquitin ligase complex targets TNFAIP1 for degradation to suppress cancer cell migration. Signal Transduction and Targeted Therapy. 5(1). 42–42. 20 indexed citations
6.
Bi, Rui, Fengqing Hu, Xuhui Yang, et al.. (2020). High hsa_circ_0020123 expression indicates poor progression to non-small cell lung cancer by regulating the miR-495/HOXC9 axis. Aging. 12(17). 17343–17352. 16 indexed citations
7.
Chen, Wen‐Lian, Xing Jin, Mingsong Wang, et al.. (2020). GLUT5-mediated fructose utilization drives lung cancer growth by stimulating fatty acid synthesis and AMPK/mTORC1 signaling. JCI Insight. 5(3). 72 indexed citations
8.
Li, Lihui, Wenjuan Zhang, Lili Cai, et al.. (2019). Validation of NEDD8-Conjugating Enzyme UBC12 As a New Therapeutic Target in Lung Cancer. SSRN Electronic Journal. 2 indexed citations
9.
Wang, Lei, Haibo Xiao, Fangbao Ding, et al.. (2019). ARHGAP24 inhibits cell proliferation and cell cycle progression and induces apoptosis of lung cancer via a STAT6-WWP2-p27 axis. Carcinogenesis. 41(5). 711–721. 34 indexed citations
10.
Li, Lihui, Wenjuan Zhang, Lili Cai, et al.. (2019). Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer. EBioMedicine. 45. 81–91. 49 indexed citations
11.
Yang, Xuhui, et al.. (2019). Mitochondrial NDUFA4L2 protein promotes the vitality of lung cancer cells by repressing oxidative stress. Thoracic Cancer. 10(4). 676–685. 25 indexed citations
12.
Wang, Lei, Mingsong Wang, Fangbao Ding, et al.. (2019). Rho GTPase Activating Protein 24 (ARHGAP24) Silencing Promotes Lung Cancer Cell Migration and Invasion by Activating β-Catenin Signaling. Medical Science Monitor. 25. 21–31. 14 indexed citations
13.
Shao, Yanjiao, Liren Wang, Shengfei Wang, et al.. (2018). Cas9-nickase–mediated genome editing corrects hereditary tyrosinemia in rats. Journal of Biological Chemistry. 293(18). 6883–6892. 41 indexed citations
14.
15.
Jiang, Lianyong, et al.. (2016). Prognostic significance of overexpressed matrix metalloproteinase-2, mouse-double minute: 2 homolog and epidermal growth factor receptor in non-small cell lung cancer.. PubMed. 21(2). 341–8. 2 indexed citations
16.
Jiang, Zhaolei, et al.. (2015). A Novel Modified Nuss Procedure for Pectus Excavatum: A New Steel Bar. The Annals of Thoracic Surgery. 99(5). 1788–1792. 10 indexed citations
17.
Zhang, Jingjing, Qian Wang, Mingsong Wang, et al.. (2015). GASZ and mitofusin‐mediated mitochondrial functions are crucial for spermatogenesis. EMBO Reports. 17(2). 220–234. 50 indexed citations
18.
Zhang, Chen, Yuanzhuo Chen, Mingsong Wang, et al.. (2014). PPM1D silencing by RNA interference inhibits the proliferation of lung cancer cells. World Journal of Surgical Oncology. 12(1). 258–258. 11 indexed citations
19.
Hu, Fengqing, Zhen Tao, Mingsong Wang, et al.. (2013). RACK1 promoted the growth and migration of the cancer cells in the progression of esophageal squamous cell carcinoma. Tumor Biology. 34(6). 3893–3899. 17 indexed citations
20.
Wang, Mingsong, Xilong Lang, Liang-jian Zou, Shengdong Huang, & Zhiyun Xu. (2010). Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: A meta-analysis based on 88 case–control studies. Atherosclerosis. 214(2). 377–385. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026